
Welltower (WELL) has caught investor attention after a strong 1 year total return and sizeable multi year gains, prompting a closer look at how its current share price lines up with key fundamentals.
See our latest analysis for Welltower.
Recent share price moves suggest interest in Welltower is still strong, with a 1 day share price return of 1.55% and a 90 day share price return of 9.87%. The 1 year total shareholder return of 47.08% and 5 year total shareholder return of 209.83% point to sustained momentum rather than a short term spike around the current US$204.70 share price.
If Welltower has you thinking more broadly about long term themes, this could be a good moment to see what else is on the move through 19 top founder-led companies
With the share price at about US$204.70 and a price target of US$229.50, plus an intrinsic value estimate that is slightly above the market price, the key question is whether there is still a buying opportunity or if the market is already fully reflecting expectations for future growth.
According to the widely followed narrative by elizabao, Welltower’s fair value of $228.14 sits above the last close of $204.70. This frames the recent share price strength in a different light.
Welltower currently has a market capitalization of roughly US$145 billion and offers a dividend yield of approximately 1.4%, which is below the broader healthcare REIT industry average of around 5%. The lower yield suggests that investors may be valuing the company more for growth potential and portfolio quality rather than income alone.
Some investors may be curious why a lower yield still lines up with a higher fair value estimate. The narrative focuses on expectations for future earnings power, margin resilience and long-run revenue expansion.
Result: Fair Value of $228.14 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this hinges on interest rates and operator health, since higher funding costs or sustained labor pressures could quickly challenge both valuation assumptions and earnings expectations.
Find out about the key risks to this Welltower narrative.
While the popular narrative points to a fair value of $228.14 and a 10.3% undervaluation, the SWS DCF model paints a different picture. On this view, Welltower’s estimated future cash flow value sits at $197.57, slightly below the current $204.70 price, which suggests a mild premium rather than a discount. Which interpretation do you think better reflects your own expectations for future cash generation?
Look into how the SWS DCF model arrives at its fair value.
If the split views in this article leave you undecided, now is a good time to review the details and assess them yourself using 1 key reward and 1 important warning sign
If you stop with just one stock, you risk missing opportunities that fit your goals even better, so put the Simply Wall St screener to work for you.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com